Sheikh O - Search Results

1

Withdrawal Notice: Management of Right Atrial Thrombus. Where is the Evidence? : A Narrative Review.

Sheikh O, Gulick D, Saenger E, Parmar R, Chilton R, Bailey S. Sheikh O, et al. Curr Cardiol Rev. 2019 Oct 23. doi: 10.2174/1573403X15666191023114546. Online ahead of print. Curr Cardiol Rev. 2019. PMID: 31657680

2

A new perspective on lowering CV risk from hypoglycaemia.

Solis-Herrera C, Sheikh O, Chilton R. Solis-Herrera C, et al. Among authors: sheikh o. Eur Heart J. 2020 Jan 7;41(2):218-220. doi: 10.1093/eurheartj/ehz730. Eur Heart J. 2020. PMID: 31605128 No abstract available.

3

Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction.

Nashawi M, Sheikh O, Battisha A, Mir M, Chilton R. Nashawi M, et al. Among authors: sheikh o. Heart Fail Rev. 2022 Jan;27(1):219-234. doi: 10.1007/s10741-020-09996-y. Heart Fail Rev. 2022. PMID: 32583230 Review.

4

Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors.

Nashawi M, Sheikh O, Battisha A, Ghali A, Chilton R. Nashawi M, et al. Among authors: sheikh o. Heart Fail Rev. 2021 May;26(3):643-652. doi: 10.1007/s10741-020-10046-w. Epub 2020 Nov 9. Heart Fail Rev. 2021. PMID: 33169337 Review.

5

The role of rivaroxaban for patients with atherosclerotic vascular disease in the modern era.

Vogt JC, Manning PG, Sheikh O, Aronow HD, Chilton RJ, Cigarroa JE. Vogt JC, et al. Among authors: sheikh o. Catheter Cardiovasc Interv. 2021 May 1;97(6):1221-1229. doi: 10.1002/ccd.29089. Epub 2020 Jul 8. Catheter Cardiovasc Interv. 2021. PMID: 32638540 No abstract available.

6

A focused review of cardiovascular guideline related recommendations for the primary care physician in the USA.

Sheikh O, Nashawi M, Battisha A, Chilton R. Sheikh O, et al. Cardiovasc Endocrinol Metab. 2020 May 15;9(2):36-41. doi: 10.1097/XCE.0000000000000192. eCollection 2020 Jun. Cardiovasc Endocrinol Metab. 2020. PMID: 32537563 Free PMC article. Review.

7

The systemic implication of novel non-statin therapies in cardiovascular diabetology: PCSK9 as a case model.

Nashawi M, Sheikh O, Mir M, Te T, Chilton R. Nashawi M, et al. Among authors: sheikh o. Cardiovasc Endocrinol Metab. 2020 May 5;9(4):143-152. doi: 10.1097/XCE.0000000000000204. eCollection 2020 Dec. Cardiovasc Endocrinol Metab. 2020. PMID: 33225229 Free PMC article. Review.

8

Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.

Lahoti S, Nashawi M, Sheikh O, Massop D, Mir M, Chilton R. Lahoti S, et al. Among authors: sheikh o. Cardiovasc Endocrinol Metab. 2020 May 18;10(1):3-13. doi: 10.1097/XCE.0000000000000209. eCollection 2021 Mar. Cardiovasc Endocrinol Metab. 2020. PMID: 33634250 Free PMC article. Review.

9

Cardiorenal protection with SGLT2: Lessons from the cardiovascular outcome trials.

Silva-Cardoso J, Sheikh O, Nashawi M, Pham S, Gallegos KM, Dinkha LR, Chilton RJ. Silva-Cardoso J, et al. Among authors: sheikh o. J Diabetes. 2020 Apr;12(4):279-293. doi: 10.1111/1753-0407.13007. Epub 2019 Dec 11. J Diabetes. 2020. PMID: 31688975 Review.

10

Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial.

Sheikh O, Vande Hei AG, Battisha A, Hammad T, Pham S, Chilton R. Sheikh O, et al. Cardiovasc Diabetol. 2019 Jun 24;18(1):84. doi: 10.1186/s12933-019-0887-0. Cardiovasc Diabetol. 2019. PMID: 31234885 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters